Midas Letter and C-Suite are excited to announce Midas Letter LIVE. Midas Letter highlights the stocks and stories to watch in the Canadian markets today. Host James West is a recognized authority on investing in the emerging company segment having been a regularly featured guest on Business News Network, CNBC, Bloomberg, Reuters, and CTV. James West and guests provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business. Midas Letter is excited to feature all investing content on C-suite.
Canopy Growth Corp (TSE:WEED | NYSE:CGC) CEO Bruce Linton on New York State Hemp License, Global Opportunities
Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1) CEO Bruce Linton joins James West for a wide-ranging discussion on the cannabis industry. Linton is thrilled with the company’s recent moves, especially Canopy’s multi-year retail partnership with convenience store giant Alimentation Couche-Tard Inc (TSE:ATD.A) (OTCMKTS:ANCUF). As capital continues to move out of the Canadian cannabis market, Canopy is increasingly looking at international opportunities. Canopy values the US space and secured a hemp license in New York State in January. Linton highlights the significance of the New York market and notes that its population, relatively small illicit market, and acceptance of CBD products make it an ideal state in which to operate. He believes intellectual property is the great differentiator in the cannabis space, as it drives new product developments and formulations. Linton is excited about the legalization of edibles, beverages, and vapes in Canada this fall and indicates the rollout process for these products will be much smoother. He’s also enthusiastic about the global medical cannabis space and sees a role for medical cannabis in Japan’s geriatric health care, as well as the potential for China to develop into a significant CBD health and wellness space.